Efficacy of Brincidofovir as prophylaxis against HSV and VZV in hematopoietic cell transplant recipients

BACKGROUND: Allogeneic hematopoietic cell transplant (HCT) recipients are at risk for herpes simplex virus (HSV) and varicella-zoster virus (VZV) infections. Routine prophylaxis with acyclovir is recommended during periods of immunosuppression. Brincidofovir (BCV, CMX001), a lipid conjugate of cidof...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Transpl Infect Dis
Main Authors: Lee, Yeon Joo, Neofytos, Dionysios, Kim, Seong Jin, Cheteyan, Leslie, Huang, Yao-Ting, Papadopoulos, Esperanza B., Jakubowski, Ann A., Papanicolaou, Genovefa A
Formato: Artigo
Idioma:Inglês
Publicado: 2018
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC6310478/
https://ncbi.nlm.nih.gov/pubmed/30120866
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/tid.12977
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares